In 2021, Panigrahi et al. [36] knocked down the RAD9 gene in prostate cancer DU145 cells and found that expression of FOXP1 were down-regulated, so migration and proliferation of tumor cell decreased. The gene discussed is FOXP1; the disease is neoplasm.